Halozyme Therapeutics, Inc.

State of Tennessee, Department of Treasury HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

57,516

Value ($000)

4,124

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	4,124	0.0%	57,516	12/31/2025
2025 Q3	11/14/2025	3,037	0.0%	41,411	9/30/2025
2025 Q2	8/15/2025	3,543	0.0%	68,116	6/30/2025
2025 Q1	5/13/2025	4,060	0.0%	63,621	3/31/2025
2024 Q4	2/13/2025	2,803	0.0%	58,621	12/31/2024
2024 Q3	11/14/2024	3,450	0.0%	60,275	9/30/2024
2024 Q2	8/13/2024	3,389	0.0%	64,728	6/30/2024
2024 Q1	5/14/2024	1,959	0.0%	48,164	3/31/2024
2023 Q4	2/14/2024	1,780	0.0%	48,164	12/31/2023
2023 Q3	11/14/2023	1,916	0.0%	50,164	9/30/2023
2023 Q2	8/15/2023	2,557	0.0%	70,894	6/30/2023
2023 Q1	5/12/2023	3,217	0.0%	84,224	3/31/2023
2022 Q4	2/15/2023	7,728	0.0%	135,812	12/31/2022
2022 Q3	1/26/2023	5,370	0.0%	135,812	9/30/2022
2022 Q2	8/15/2022	5,544	0.0%	126,009	6/30/2022
2022 Q1	5/11/2022	2,632	0.0%	66,009	3/31/2022
2021 Q4	2/15/2022	2,252	0.0%	56,009	12/31/2021
2021 Q3	11/12/2021	2,279	0.0%	56,009	9/30/2021
2021 Q2	8/11/2021	2,797	0.0%	61,587	6/30/2021
2021 Q1	5/10/2021	5,903	0.0%	141,587	3/31/2021
2020 Q4	2/9/2021	4,698	0.0%	110,000	12/31/2020